January 1, 2008Thrombosis and Haemostasis

Bivalirudin

View Full Paper

Ask AI

Bookmark

Population

Patients undergoing invasive cardiology procedures, particularly percutaneous coronary intervention, or…

Design

Review

Authors

AGAndreas GreinacherUniversità Cattolica del Sacro Cuore AKAndreas KosterInterventional / Structural Cardiology TWTheodore E. WarkentinHamilton General Hospital

Discussion

Member takes

Implication

May inform HIT anticoagulation choices in PCI; literature review leaves open comparative trials versus current alternatives.

Structured PICO

Population

Patients undergoing invasive cardiology procedures, particularly percutaneous coronary intervention (PCI), or cardiac surgery, including those with or at risk of heparin-induced thrombocytopenia (HIT).

Intervention

Bivalirudin

Bivalirudin is a direct thrombin inhibitor with a unique pharmacologic profile, primarily used for anticoagulation during PCI and cardiac surgery, including in patients with HIT.

Cite This Study

Greinacher et al. (2008) studied this question.

synapsesocial.com/papers/6a8c7dd830b08b45d7d3cb8a https://doi.org/10.1160/th07-10-0644

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Bivalirudin

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Bivalirudin

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider